$4.13
+0.270 (+6.99%)
At Close: Jun 23, 2026
Repro Med Systems, Inc. (KRMD) Reports Q4 Loss, Tops Revenue Estimates
10:25pm, Wednesday, 02'nd Mar 2022 Zacks Investment Research
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 5.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the sto
Repro Med Systems, Inc. (KRMD) CEO Linda Tharby on Q4 2021 Results - Earnings Call Transcript
09:29pm, Wednesday, 02'nd Mar 2022
Repro Med Systems, Inc. (KRMD) CEO Linda Tharby on Q4 2021 Results - Earnings Call Transcript
Repro Med Systems GAAP EPS of -$0.02 beats by $0.01, revenue of $6.5M beats by $0.44M
09:06pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
Repro Med Systems press release (KRMD): Q4 GAAP EPS of -$0.02 beats by $0.01.Revenue of $6.5M (+60.1% Y/Y) beats by $0.44M.
Repro Med Systems, Inc. (KRMD) Reports Q4 Loss, Tops Revenue Estimates
07:06pm, Wednesday, 02'nd Mar 2022
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 5.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the sto
Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates
11:25pm, Monday, 28'th Feb 2022 Zacks Investment Research
Veracyte (VCYT) delivered earnings and revenue surprises of -7.14% and 6.07%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
10:40pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Silk Road Medical (SILK) delivered earnings and revenue surprises of -5% and 8.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for
08:00pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for
04:09pm, Wednesday, 23'rd Feb 2022
Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
12:30am, Tuesday, 22'nd Feb 2022
CHESTER, N.Y.--(BUSINESS WIRE)--First paragraph, first sentence of release dated February 16, 2022, should read: Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
12:41pm, Wednesday, 22'nd Dec 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Allakos's Lirentelimab Flunks Late-Stage Studies In Patients With Inflammation In Digestive Tract
Alla
Acuitas Investments LLC Buys 63,321 Shares of Repro Med Systems, Inc. (NASDAQ:KRMD)
01:58pm, Tuesday, 14'th Dec 2021 Dakota Financial News
Acuitas Investments LLC increased its holdings in shares of Repro Med Systems, Inc. (NASDAQ:KRMD) by 33.9% during the third quarter, Holdings Channel reports. The fund owned 250,342 shares of the company’s stock after purchasing an additional 63,321 shares during the period. Acuitas Investments LLC’s holdings in Repro Med Systems were worth $713,000 at the end […]
Adirondack Retirement Specialists Inc. Has $497,000 Position in Repro Med Systems, Inc. (NASDAQ:KRMD)
02:12pm, Saturday, 27'th Nov 2021 Transcript Daily
Adirondack Retirement Specialists Inc. increased its position in shares of Repro Med Systems, Inc. (NASDAQ:KRMD) by 206.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 174,501 shares of the companys stock after acquiring an additional 117,484 shares during the period. Repro Med Systems []
Vanguard Group Inc. Reduces Stake in Repro Med Systems, Inc. (NASDAQ:KRMD)
09:14am, Saturday, 20'th Nov 2021 Transcript Daily
Vanguard Group Inc. decreased its stake in shares of Repro Med Systems, Inc. (NASDAQ:KRMD) by 20.6% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 1,358,412 shares of the companys stock after selling 352,560 shares during the period. Vanguard Group Inc.s holdings in Repro Med Systems were []
Repro Med Systems, Inc. (KRMD) CEO Linda Tharby on Q3 2021 Results - Earnings Call Transcript
09:01pm, Wednesday, 10'th Nov 2021
Repro Med Systems, Inc. (KRMD) CEO Linda Tharby on Q3 2021 Results - Earnings Call Transcript
Repro Med Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
06:19pm, Wednesday, 10'th Nov 2021
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s
Sign In
Buy KRMD